Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7537266rdf:typepubmed:Citationlld:pubmed
pubmed-article:7537266lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7537266lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7537266lifeskim:mentionsumls-concept:C0002210lld:lifeskim
pubmed-article:7537266lifeskim:mentionsumls-concept:C0677626lld:lifeskim
pubmed-article:7537266lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:7537266lifeskim:mentionsumls-concept:C0085943lld:lifeskim
pubmed-article:7537266lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:7537266lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:7537266pubmed:issue17lld:pubmed
pubmed-article:7537266pubmed:dateCreated1995-6-1lld:pubmed
pubmed-article:7537266pubmed:abstractTextThe effects of a phorbol ester (TPA) and of members of the Jun and Fos oncoprotein family on the activity of the rat alpha-fetoprotein (AFP) promoter were checked by using transient expression experiments in HepG2 hepatoma cells. TPA blocked the activity of the rat AFP promoter in a dose-dependent manner. Overexpression of c-Jun specifically repressed the rat AFP promoter but not the albumin promoter. JunB and JunD were poorer inhibitors. c-Fos expression did not potentiate the negative effect of Jun. The Jun-induced repression does not require binding of c-Jun to the AFP promoter. DNase 1 footprinting experiments did not display any high affinity binding site for Jun on the AFP promoter. Integrity of the c-Jun DNA binding domain is not required for the c-Jun protein to block the AFP promoter. The N-terminal part of Jun, which contains the activating domain, is responsible for the repression as shown by using Jun-Gal4 chimera. Jun likely exerts its negative control on the AFP promoter via protein-protein interactions with a not yet identified trans-activating factor within the -134 to +6 region or with a component of the general machinery of transcription. Jun proteins can thus be key intermediates in regulatory cascades which result in the differential modulation of the AFP and albumin gene expression in the course of liver development and carcinogenesis.lld:pubmed
pubmed-article:7537266pubmed:languageenglld:pubmed
pubmed-article:7537266pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7537266pubmed:citationSubsetIMlld:pubmed
pubmed-article:7537266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7537266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7537266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7537266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7537266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7537266pubmed:statusMEDLINElld:pubmed
pubmed-article:7537266pubmed:monthAprlld:pubmed
pubmed-article:7537266pubmed:issn0021-9258lld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:FeldmannGGlld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:BernuauDDlld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:ThomassinHHlld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:Bois-JoyeuxBBlld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:DananJ LJLlld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:DenissenkoMMlld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:GuesdonSSlld:pubmed
pubmed-article:7537266pubmed:authorpubmed-author:IkonomovaRRlld:pubmed
pubmed-article:7537266pubmed:issnTypePrintlld:pubmed
pubmed-article:7537266pubmed:day28lld:pubmed
pubmed-article:7537266pubmed:volume270lld:pubmed
pubmed-article:7537266pubmed:geneSymbolc-junlld:pubmed
pubmed-article:7537266pubmed:ownerNLMlld:pubmed
pubmed-article:7537266pubmed:authorsCompleteYlld:pubmed
pubmed-article:7537266pubmed:pagination10204-11lld:pubmed
pubmed-article:7537266pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:meshHeadingpubmed-meshheading:7537266-...lld:pubmed
pubmed-article:7537266pubmed:year1995lld:pubmed
pubmed-article:7537266pubmed:articleTitleThe c-jun proto-oncogene down-regulates the rat alpha-fetoprotein promoter in HepG2 hepatoma cells without binding to DNA.lld:pubmed
pubmed-article:7537266pubmed:affiliationCentre de Recherche sur l'Endocrinologie Moléculaire et le Développement, CNRS, UPR 1511, Meudon, France.lld:pubmed
pubmed-article:7537266pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7537266pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7537266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7537266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7537266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7537266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7537266lld:pubmed